Travel and the immunocompromised host.
Increasing opportunities for travel and advances in medicine mean that immunocompromised patients may venture to potentially risky parts of the world. This article examines the risks faced by such travellers. Some limitations of standard travel vaccines are discussed and suggestions are made as to how best to advise such travellers.
Conlon
C P
CP
Nuffield Department of Medicine, John Radcliffe Hospital, Oxford.
D000970:Antineoplastic Agents / Q000009:adverse effects; D002908:Chronic Disease; D005260:Female; D015658:HIV Infections / Q000276:immunology; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D010353:Patient Education as Topic; D013156:Splenectomy / Q000009:adverse effects; D014181:Transplantation Immunology; D014195:Travel; D014612:Vaccines / Q000008:administration & dosage* / Q000009:adverse effects
D000970:Antineoplastic Agents; D014612:Vaccines